The Hispanic EPESE provides data on risk factors for mortality and morbidity in Mexican Americans in order to contrast how these factors operate differently in non-Hispanic White Americans, African Americans, and other major ethnic groups. The Wave 8 dataset comprises the seventh follow-up of the baseline Hispanic EPESE (HISPANIC ESTABLISHED POPULATIONS FOR THE EPIDEMIOLOGIC STUDIES OF THE ELDERLY, 1993-1994: [ARIZONA, CALIFORNIA, COLORADO, NEW MEXICO, AND TEXAS] [ICPSR 2851]). The baseline Hispanic EPESE collected data on a representative sample of community-dwelling Mexican Americans, aged 65 years and older, residing in the five southwestern states of Arizona, California, Colorado, New Mexico, and Texas. The public-use data cover demographic characteristics (age, sex, marital status), height, weight, BMI, social and physical functioning, chronic conditions, related health problems, health habits, self-reported use of hospital and nursing home services, and depression. Subsequent follow-ups provide a cross-sectional examination of the predictors of mortality, changes in health outcomes, and institutionalization, and other changes in living arrangements, as well as changes in life situations and quality of life issues. During this 8th Wave, 2012-2013, re-interviews were conducted either in person or by proxy, with 452 of the original respondents. This Wave also includes 292 re-interviews from the additional sample of Mexican Americans aged 75 years and over with higher average-levels of education than those of the surviving cohort who were added in Wave 5, increasing the total number of respondents to 744.

Map made for VIDA storymap, http://nmcdc.maps.arcgis.com/apps/Cascade/index.html?appid=a55bb730dbea4a5da9c706b748b72e44, for question/section 4: "What are the health conditions?" showing characteristics of health and health outcomes in remote small areas across New Mexico, including deaths of despair.Deaths of despair, also known as deaths from diseases of despair, include deaths from suicide, drug and alcohol overdose and alcoholic liver disease. It is measured in potential years of life lost (PYLL) based on an average life span of 75 years. For more information on remote small areas in this context, please see story map at above link or see details at the source feature layer:Containing Rural areas as defined by US Census 2013 urban/rural defined areas, http://nmcdc.maps.arcgis.com/home/item.html?id=fbd1e91ec0a54c58b6fcca8a5138c1fc. Remote is filtered to include: 'RURAL' in 2 category designation, Population of LESS THAN 5001 persons, AND % Low access low-income at 20 miles to AT LEAST 5% for census tracts and small areas that contain a remote census tract are selected.

Map was updated in 2022 with (2013- 2017) five year birth rates for eight different indicators. Adolescent Fertility (Teen Birth) Rates and Trends, as well as Births By Attendant and Mother's Education. Also depicts population birth rates and percent first born births for the years 1998 through 2013.Comparing the years 2000-04 to the years 2005-09, adolescent fertility rates in NM trended down by 5.3% for women age 15-17 and up by 2.5% for women age 18-19. Comparing the years 2000-04 to the years 2009-13, adolescent fertility rates in NM trended down by 40.6% for women age 15-17 and down by 18.6% for women age 18-19.5 year counts and percentages of births by type of birth attendant for 108 NM Small Areas. In New Mexico (2005-2009) 68% of births were attended by a physician, 27% by a Certified Nurse Midwife, and 2.3% by a Licensed Midwife."Sixty-eight percent of births are attended by a midwife in Britain and 45 percent in the Netherlands, compared with 8 percent in the United States." - https://www.nytimes.com/2013/07/01/health/american-way-of-birth-costliest-in-the-world.htmlSource:Birth Data - NM Department of Health, Vital Records and Health Statistics Bureau, via https://ibis.health.state.nm.us/query/result/birth/BirthPopSarea/FertRate.html

Map was updated in 2022 with (2013- 2017) five year birth rates for eight different indicators. Adolescent Fertility (Teen Birth) Rates and Trends, as well as Births By Attendant and Mother's Education. Also depicts population birth rates and percent first born births for the years 1998 through 2013.Comparing the years 2000-04 to the years 2005-09, adolescent fertility rates in NM trended down by 5.3% for women age 15-17 and up by 2.5% for women age 18-19. Comparing the years 2000-04 to the years 2009-13, adolescent fertility rates in NM trended down by 40.6% for women age 15-17 and down by 18.6% for women age 18-19.5 year counts and percentages of births by type of birth attendant for 108 NM Small Areas. In New Mexico (2005-2009) 68% of births were attended by a physician, 27% by a Certified Nurse Midwife, and 2.3% by a Licensed Midwife. "Sixty-eight percent of births are attended by a midwife in Britain and 45 percent in the Netherlands, compared with 8 percent in the United States." - https://www.nytimes.com/2013/07/01/health/american-way-of-birth-costliest-in-the-world.htmlSource:Birth Data - NM Department of Health, Vital Records and Health Statistics Bureau, via https://ibis.health.state.nm.us/query/result/birth/BirthPopSarea/FertRate.html

This dataset comprises the third follow-up of the baseline Hispanic EPESE, HISPANIC ESTABLISHED POPULATIONS FOR THE EPIDEMIOLOGIC STUDIES OF THE ELDERLY, 1993-1994: ARIZONA, CALIFORNIA, COLORADO, NEW MEXICO, AND TEXAS, and provides information on 1,682 of the original respondents. The Hispanic EPESE collected data on a representative sample of community-dwelling Mexican-American elderly, aged 65 years and older, residing in the five southwestern states of Arizona, California, Colorado, New Mexico, and Texas. The primary purpose of the series was to provide estimates of the prevalence of key physical health conditions, mental health conditions, and functional impairments in older Mexican Americans and to compare these estimates with those for other populations. The Hispanic EPESE attempted to determine whether certain risk factors for mortality and morbidity operate differently in Mexican Americans than in non-Hispanic White Americans, African Americans, and other major ethnic groups. The public-use data cover background characteristics (age, sex, type of Hispanic race, income, education, marital status, number of children, employment, and religion), height, weight, social and physical functioning, chronic conditions, related health problems, health habits, self-reported use of dental, hospital, and nursing home services, and depression. The follow-ups provide a cross-sectional examination of the predictors of mortality, changes in health outcomes, and institutionalization and other changes in living arrangements, as well as changes in life situations and quality of life issues. The vital status of respondents from baseline to this round of the survey may be determined using the Vital Status file (Part 2). This file contains interview dates from the baseline as well as vital status at Wave IV (respondent survived, date of death if deceased, proxy-assisted, proxy-reported cause of death, proxy-true). The first follow-up of the baseline data (Hispanic EPESE Wave II, 1995-1996 [ICPSR 3385]) followed 2,438 of the original 3,050 respondents, and the second follow-up (Hispanic EPESE Wave III, 1998-1999 [ICPSR 4102]) followed 1,980 of these respondents. Hispanic EPESE, 1993-1994 (ICPSR 2851), was modeled after the design of ESTABLISHED POPULATIONS FOR EPIDEMIOLOGIC STUDIES OF THE ELDERLY, 1981-1993: EAST BOSTON, MASSACHUSETTS, IOWA AND WASHINGTON COUNTIES, IOWA, NEW HAVEN, CONNECTICUT, AND NORTH CENTRAL NORTH CAROLINA and ESTABLISHED POPULATIONS FOR EPIDEMIOLOGIC STUDIES OF THE ELDERLY, 1996-1997: PIEDMONT HEALTH SURVEY OF THE ELDERLY, FOURTH IN-PERSON SURVEY DURHAM, WARREN, VANCE, GRANVILLE, AND FRANKLIN COUNTIES, NORTH CAROLINA.

Data for CDC’s COVID Data Tracker site on Rates of COVID-19 Cases and Deaths by Vaccination Status. Click 'More' for important dataset description and footnotes

Dataset and data visualization details: These data were posted on October 21, 2022, archived on November 18, 2022, and revised on February 22, 2023. These data reflect cases among persons with a positive specimen collection date through September 24, 2022, and deaths among persons with a positive specimen collection date through September 3, 2022.

Vaccination status: A person vaccinated with a primary series had SARS-CoV-2 RNA or antigen detected on a respiratory specimen collected ≥14 days after verifiably completing the primary series of an FDA-authorized or approved COVID-19 vaccine. An unvaccinated person had SARS-CoV-2 RNA or antigen detected on a respiratory specimen and has not been verified to have received COVID-19 vaccine. Excluded were partially vaccinated people who received at least one FDA-authorized vaccine dose but did not complete a primary series ≥14 days before collection of a specimen where SARS-CoV-2 RNA or antigen was detected. Additional or booster dose: A person vaccinated with a primary series and an additional or booster dose had SARS-CoV-2 RNA or antigen detected on a respiratory specimen collected ≥14 days after receipt of an additional or booster dose of any COVID-19 vaccine on or after August 13, 2021. For people ages 18 years and older, data are graphed starting the week including September 24, 2021, when a COVID-19 booster dose was first recommended by CDC for adults 65+ years old and people in certain populations and high risk occupational and institutional settings. For people ages 12-17 years, data are graphed starting the week of December 26, 2021, 2 weeks after the first recommendation for a booster dose for adolescents ages 16-17 years. For people ages 5-11 years, data are included starting the week of June 5, 2022, 2 weeks after the first recommendation for a booster dose for children aged 5-11 years. For people ages 50 years and older, data on second booster doses are graphed starting the week including March 29, 2022, when the recommendation was made for second boosters. Vertical lines represent dates when changes occurred in U.S. policy for COVID-19 vaccination (details provided above). Reporting is by primary series vaccine type rather than additional or booster dose vaccine type. The booster dose vaccine type may be different than the primary series vaccine type. ** Because data on the immune status of cases and associated deaths are unavailable, an additional dose in an immunocompromised person cannot be distinguished from a booster dose. This is a relevant consideration because vaccines can be less effective in this group. Deaths: A COVID-19–associated death occurred in a person with a documented COVID-19 diagnosis who died; health department staff reviewed to make a determination using vital records, public health investigation, or other data sources. Rates of COVID-19 deaths by vaccination status are reported based on when the patient was tested for COVID-19, not the date they died. Deaths usually occur up to 30 days after COVID-19 diagnosis. Participating jurisdictions: Currently, these 31 health departments that regularly link their case surveillance to immunization information system data are included in these incidence rate estimates: Alabama, Arizona, Arkansas, California, Colorado, Connecticut, District of Columbia, Florida, Georgia, Idaho, Indiana, Kansas, Kentucky, Louisiana, Massachusetts, Michigan, Minnesota, Nebraska, New Jersey, New Mexico, New York, New York City (New York), North Carolina, Philadelphia (Pennsylvania), Rhode Island, South Dakota, Tennessee, Texas, Utah, Washington, and West Virginia; 30 jurisdictions also report deaths among vaccinated and unvaccinated people. These jurisdictions represent 72% of the total U.S. population and all ten of the Health and Human Services Regions. Data on cases

This file contains COVID-19 death counts and rates by month and year of death, jurisdiction of residence (U.S., HHS Region) and demographic characteristics (sex, age, race and Hispanic origin, and age/race and Hispanic origin). United States death counts and rates include the 50 states, plus the District of Columbia. Deaths with confirmed or presumed COVID-19, coded to ICD–10 code U07.1. Number of deaths reported in this file are the total number of COVID-19 deaths received and coded as of the date of analysis and may not represent all deaths that occurred in that period. Counts of deaths occurring before or after the reporting period are not included in the file. Data during recent periods are incomplete because of the lag in time between when the death occurred and when the death certificate is completed, submitted to NCHS and processed for reporting purposes. This delay can range from 1 week to 8 weeks or more, depending on the jurisdiction and cause of death. Death counts should not be compared across jurisdictions. Data timeliness varies by state. Some states report deaths on a daily basis, while other states report deaths weekly or monthly. The ten (10) United States Department of Health and Human Services (HHS) regions include the following jurisdictions. Region 1: Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island, Vermont; Region 2: New Jersey, New York; Region 3: Delaware, District of Columbia, Maryland, Pennsylvania, Virginia, West Virginia; Region 4: Alabama, Florida, Georgia, Kentucky, Mississippi, North Carolina, South Carolina, Tennessee; Region 5: Illinois, Indiana, Michigan, Minnesota, Ohio, Wisconsin; Region 6: Arkansas, Louisiana, New Mexico, Oklahoma, Texas; Region 7: Iowa, Kansas, Missouri, Nebraska; Region 8: Colorado, Montana, North Dakota, South Dakota, Utah, Wyoming; Region 9: Arizona, California, Hawaii, Nevada; Region 10: Alaska, Idaho, Oregon, Washington. Rates were calculated using the population estimates for 2021, which are estimated as of July 1, 2021 based on the Blended Base produced by the US Census Bureau in lieu of the April 1, 2020 decennial population count. The Blended Base consists of the blend of Vintage 2020 postcensal population estimates, 2020 Demographic Analysis Estimates, and 2020 Census PL 94-171 Redistricting File (see https://www2.census.gov/programs-surveys/popest/technical-documentation/methodology/2020-2021/methods-statement-v2021.pdf). Rate are based on deaths occurring in the specified week and are age-adjusted to the 2000 standard population using the direct method (see https://www.cdc.gov/nchs/data/nvsr/nvsr70/nvsr70-08-508.pdf). These rates differ from annual age-adjusted rates, typically presented in NCHS publications based on a full year of data and annualized weekly age-adjusted rates which have been adjusted to allow comparison with annual rates. Annualization rates presents deaths per year per 100,000 population that would be expected in a year if the observed period specific (weekly) rate prevailed for a full year. Sub-national death counts between 1-9 are suppressed in accordance with NCHS data confidentiality standards. Rates based on death counts less than 20 are suppressed in accordance with NCHS standards of reliability as specified in NCHS Data Presentation Standards for Proportions (available from: https://www.cdc.gov/nchs/data/series/sr_02/sr02_175.pdf.).

35 to 44 years Health Insurance Coverage Statistics for 2023. This is part of a larger dataset covering consumer health insurance coverage rates in Albuquerque, New Mexico by age, education, race, gender, work experience and more.

Data for CDC’s COVID Data Tracker site on Rates of COVID-19 Cases and Deaths by Vaccination Status. Click 'More' for important dataset description and footnotes

Dataset and data visualization details: These data were posted on October 21, 2022, archived on November 18, 2022, and revised on February 22, 2023. These data reflect cases among persons with a positive specimen collection date through September 24, 2022, and deaths among persons with a positive specimen collection date through September 3, 2022.

Vaccination status: A person vaccinated with a primary series had SARS-CoV-2 RNA or antigen detected on a respiratory specimen collected ≥14 days after verifiably completing the primary series of an FDA-authorized or approved COVID-19 vaccine. An unvaccinated person had SARS-CoV-2 RNA or antigen detected on a respiratory specimen and has not been verified to have received COVID-19 vaccine. Excluded were partially vaccinated people who received at least one FDA-authorized vaccine dose but did not complete a primary series ≥14 days before collection of a specimen where SARS-CoV-2 RNA or antigen was detected. Additional or booster dose: A person vaccinated with a primary series and an additional or booster dose had SARS-CoV-2 RNA or antigen detected on a respiratory specimen collected ≥14 days after receipt of an additional or booster dose of any COVID-19 vaccine on or after August 13, 2021. For people ages 18 years and older, data are graphed starting the week including September 24, 2021, when a COVID-19 booster dose was first recommended by CDC for adults 65+ years old and people in certain populations and high risk occupational and institutional settings. For people ages 12-17 years, data are graphed starting the week of December 26, 2021, 2 weeks after the first recommendation for a booster dose for adolescents ages 16-17 years. For people ages 5-11 years, data are included starting the week of June 5, 2022, 2 weeks after the first recommendation for a booster dose for children aged 5-11 years. For people ages 50 years and older, data on second booster doses are graphed starting the week including March 29, 2022, when the recommendation was made for second boosters. Vertical lines represent dates when changes occurred in U.S. policy for COVID-19 vaccination (details provided above). Reporting is by primary series vaccine type rather than additional or booster dose vaccine type. The booster dose vaccine type may be different than the primary series vaccine type. ** Because data on the immune status of cases and associated deaths are unavailable, an additional dose in an immunocompromised person cannot be distinguished from a booster dose. This is a relevant consideration because vaccines can be less effective in this group. Deaths: A COVID-19–associated death occurred in a person with a documented COVID-19 diagnosis who died; health department staff reviewed to make a determination using vital records, public health investigation, or other data sources. Rates of COVID-19 deaths by vaccination status are reported based on when the patient was tested for COVID-19, not the date they died. Deaths usually occur up to 30 days after COVID-19 diagnosis. Participating jurisdictions: Currently, these 31 health departments that regularly link their case surveillance to immunization information system data are included in these incidence rate estimates: Alabama, Arizona, Arkansas, California, Colorado, Connecticut, District of Columbia, Florida, Georgia, Idaho, Indiana, Kansas, Kentucky, Louisiana, Massachusetts, Michigan, Minnesota, Nebraska, New Jersey, New Mexico, New York, New York City (New York), North Carolina, Philadelphia (Pennsylvania), Rhode Island, South Dakota, Tennessee, Texas, Utah, Washington, and West Virginia; 30 jurisdictions also report deaths among vaccinated and unvaccinated people. These jurisdictions represent 72% of the total U.S. population and all ten of the Health and Human Services Regions. Data on cases

In 2023, the total fertility rate in Mexico decreased by 0.03 children per woman (-1.55 percent) compared to 2022. This marks the lowest fertility rate during the observed period. The total fertility rate is the average number of children that a woman of childbearing age (generally considered 15 to 44 years) is expected to have throughout her reproductive years. Unlike birth rates, which are based on the actual number of live births in a given population, fertility rates are estimates (similar to life expectancy) that apply to a hypothetical woman, as they assume that current patterns in age-specific fertility will remain constant throughout her reproductive years.Find more statistics on other topics about Mexico with key insights such as death rate, total life expectancy at birth, and life expectancy of women at birth.

Mexico Average Years in School: Population: 15 Years & Above: Female: Nuevo Leon data was reported at 10.600 Year in 2020. This records an increase from the previous number of 10.080 Year for 2015. Mexico Average Years in School: Population: 15 Years & Above: Female: Nuevo Leon data is updated yearly, averaging 9.855 Year from Dec 2000 (Median) to 2020, with 4 observations. The data reached an all-time high of 10.600 Year in 2020 and a record low of 8.600 Year in 2000. Mexico Average Years in School: Population: 15 Years & Above: Female: Nuevo Leon data remains active status in CEIC and is reported by National Institute of Statistics and Geography. The data is categorized under Global Database’s Mexico – Table MX.G016: Education Statistics: Age 15 and Above.

In 2022, the leading causes of death among children and adolescents in the United States aged 10 to 14 were unintentional injuries, intentional self-harm (suicide), and cancer. That year, unintentional injuries accounted for around 25 percent of all deaths among this age group. Leading causes of death among older teens Like those aged 10 to 14 years, the leading cause of death among older teenagers in the U.S. aged 15 to 19 years is unintentional injuries. In 2022, unintentional injuries accounted for around 37 percent of all deaths among older teens. However, unlike those aged 10 to 14, the second leading cause of death among teens aged 15 to 19 is assault or homicide. Sadly, the third leading cause of death among this age group is suicide, making suicide among the leading three causes of death for both age groups. Teen suicide Suicide remains a major problem among teenagers in the United States, as reflected in the leading causes of death among this age group. It was estimated that in 2021, around 22 percent of high school students in the U.S. considered attempting suicide in the past year, with this rate twice as high for girls than for boys. The states with the highest death rates due to suicide among adolescents aged 15 to 19 years are Montana, South Dakota, and New Mexico. In 2022, the death rate from suicide among this age group in Montana was 39 per 100,000 population. In comparison, New York, the state with the lowest rate, had just five suicide deaths among those aged 15 to 19 years per 100,000 population.

Population 19 to 64 years Health Insurance Coverage Statistics for 2022. This is part of a larger dataset covering consumer health insurance coverage rates in Bernalillo, New Mexico by age, education, race, gender, work experience and more.

Under 19 years Health Insurance Coverage Statistics for 2022. This is part of a larger dataset covering consumer health insurance coverage rates in Bernalillo, New Mexico by age, education, race, gender, work experience and more.

35 to 44 years Health Insurance Coverage Statistics for 2023. This is part of a larger dataset covering consumer health insurance coverage rates in McKinley County, New Mexico by age, education, race, gender, work experience and more.

Total household population Health Insurance Coverage Statistics for 2023. This is part of a larger dataset covering consumer health insurance coverage rates in Albuquerque, New Mexico by age, education, race, gender, work experience and more.

35 to 44 years Health Insurance Coverage Statistics for 2022. This is part of a larger dataset covering consumer health insurance coverage rates in Eddy County, New Mexico by age, education, race, gender, work experience and more.

Total household population Health Insurance Coverage Statistics for 2023. This is part of a larger dataset covering consumer health insurance coverage rates in McKinley County, New Mexico by age, education, race, gender, work experience and more.

35 to 44 years Health Insurance Coverage Statistics for 2022. This is part of a larger dataset covering consumer health insurance coverage rates in White Rock, New Mexico by age, education, race, gender, work experience and more.

Population 26 years and over Health Insurance Coverage Statistics for 2022. This is part of a larger dataset covering consumer health insurance coverage rates in Tucumcari, New Mexico by age, education, race, gender, work experience and more.